Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia

Chel Hee Lee,Mohammad M. Banoei,Mariam Ansari,Matthew P. Cheng,Francois Lamontagne,Donald Griesdale,David E. Lasry,Koray Demir,Vinay Dhingra,Karen C. Tran,Terry Lee,Kevin Burns,David Sweet,John Marshall,Arthur Slutsky,Srinivas Murthy,Joel Singer,David M. Patrick,Todd C. Lee,John H. Boyd,Keith R. Walley,Robert Fowler,Greg Haljan,Donald C. Vinh,Alison Mcgeer,David Maslove,Puneet Mann,Kathryn Donohoe,Geraldine Hernandez,Genevieve Rocheleau,Uriel Trahtemberg,Anand Kumar,Ma Lou,Claudia dos Santos,Andrew Baker,James A. Russell,Brent W. Winston,J. A. Russell,K. R. Walley,J. Boyd,T. Lee,J. Singer,D. Sweet,K. Tran,S. Reynolds,G. Haljan,M. Cheng,D. Vinh,T. Lee,F. Lamontagne,B. Winston,O. Rewa,J. Marshall,A. Slutsky,A. McGeer,V. Sivanantham,R. Fowler,D. Maslove,S. Perez Patrigeon,K. D. Burns,for the *ARBs CORONA I. Investigators
DOI: https://doi.org/10.1186/s13054-024-04843-0
IF: 15.1
2024-02-29
Critical Care
Abstract:Acute respiratory distress syndrome (ARDS) is a life-threatening critical care syndrome commonly associated with infections such as COVID-19, influenza, and bacterial pneumonia. Ongoing research aims to improve our understanding of ARDS, including its molecular mechanisms, individualized treatment options, and potential interventions to reduce inflammation and promote lung repair.
critical care medicine
What problem does this paper attempt to address?